Inhibition of tumor necrosis factor alpha and ankylosing spondylitis.
作者信息
Marzo-Ortega Helena, Emery Paul, McGonagle Dennis
出版信息
N Engl J Med. 2003 Jan 23;348(4):359-61; author reply 359-61.
PMID:12542065
Abstract
摘要
相似文献
1
Inhibition of tumor necrosis factor alpha and ankylosing spondylitis.
N Engl J Med. 2003 Jan 23;348(4):359-61; author reply 359-61.
2
[Anti-TNF alfa therapy in ankylosing spondylitis].
Acta Med Port. 2006 Mar-Apr;19(2):141-50. Epub 2006 Aug 18.
3
Anti-TNF-alpha therapy for ankylosing spondylitis--a specific or nonspecific treatment?
N Engl J Med. 2002 May 2;346(18):1399-400. doi: 10.1056/NEJM200205023461811.
4
The anti-TNF revolution in ankylosing spondylitis: patients with severe disease now have access to promising new drugs.
Med J Aust. 2004 Nov 15;181(10):529-30.
5
Etanercept (Enbrel) -- an update.
Skin Therapy Lett. 2004;9(10):1-4, 9.
6
[TNF-alpha inhibitors].
Rev Prat. 2003 Nov 30;53(18):1989-90.
7
Wider use for Enbrel.
FDA Consum. 2003 Nov-Dec;37(6):7.
8
Alopecia areata during etanercept therapy.
Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):127-9. doi: 10.1080/09273940802596559.
9
Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C.
Arthritis Rheum. 2006 Jul;54(7):2335-7. doi: 10.1002/art.21949.
10
Tumour necrosis factor inhibitors in ankylosing spondylitis.
Intern Med J. 2008 Oct;38(10):781-9. doi: 10.1111/j.1445-5994.2008.01639.x. Epub 2008 Apr 14.
Zotero 插件